Skip to content
drillr.ai
Sign up

RAPP

Rapport Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$24.21
+7.60%
Ask drillr
7
Insider buys (3m)
20
Insider sells (3m)
-$5.3M
Net value (3m)
-42.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 23, 2026Sanchez Ramiro · directorPurchase3,600$27
Oct 23, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale2,210$29
Oct 22, 2026Silva Paul M · directorPurchase3,680$27
Oct 22, 2026MARAGANORE JOHN · directorPurchase1,172$27
Oct 22, 2026MARAGANORE JOHN · directorPurchase8,239$26
Oct 22, 2026PAUL STEVEN M · directorPurchase35,714$27
Oct 22, 2026Young Wendy B. · directorPurchase3,789$26
Oct 21, 2026Ignelzi Troy A. · officer: Chief Financial OfficerPurchase5,500$26
Oct 8, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale3,375$32
Oct 8, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale1,147$31
Oct 1, 2026Gault Cheryl · officer: Chief Operating OfficerSale2,075$34
Oct 1, 2026Gault Cheryl · officer: Chief Operating OfficerSale7,925$33
Sep 24, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale43$41
Sep 24, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale215$40
Sep 24, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale1,952$39
Sep 9, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale7,141$46
Sep 9, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale1,069$46
Aug 26, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale20,799$50
Aug 26, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale16,201$51
Aug 26, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale13,160$50
Aug 26, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale18,921$50
Aug 20, 2026Yeleswaram Krishnaswamy · officer: Chief Development OfficerSale404$50
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale8,370$47
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale14,171$46
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale19,500$48
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale5,794$49
Aug 12, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale3,664$47
Jul 29, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale7$43
Jul 29, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale2,203$42
Jul 15, 2026Ceesay Abraham · director, officer: Chief Executive OfficerSale2,729$41
Institutional positioning

13F filings over the trailing two quarters

New 66Increased 114Reduced 79Sold out 19
FilerActionSharesFiled
FMR LLCIncreased7,172,894Aug 13, 2026
FMR LLCIncreased7,168,939May 15, 2026
TRV GP V, LLCUnchanged7,135,233May 7, 2026
TRV GP V, LLCReduced6,280,525Aug 10, 2026
ARCH Venture Management, LLCUnchanged3,728,738Aug 14, 2026
ARCH VENTURE MANAGEMENT, LLCUnchanged3,728,738May 15, 2026
CAPITAL INTERNATIONAL INVESTORSReduced3,097,973May 13, 2026
CORMORANT ASSET MANAGEMENT, LPReduced2,957,521May 15, 2026
GOLDMAN SACHS GROUP INCReduced2,942,251May 15, 2026
Capital International InvestorsReduced2,921,958Aug 12, 2026
GOLDMAN SACHS GROUP INCReduced2,910,449Aug 14, 2026
BlackRock, Inc.Increased2,699,786Aug 7, 2026
Cormorant Asset Management, LPReduced2,657,521Aug 14, 2026
BLACKROCK, INC.Increased2,505,955May 13, 2026
Sofinnova Investments, Inc.Unchanged1,904,408Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 23, 2026